Chemotherapy toxicity assessment using a self-report tool.
OBJECTIVE
To improve the data collection process for patients participating in clinical trials and to ensure patient safety.


METHODS
Clinical trial toxicity assessment forms and clinical experience.


RESULTS
A comprehensive self-report form was developed to collect information regarding the toxicity experienced. The form was designed to be easy for patients to complete and nurses/physicians to interpret.


CONCLUSIONS
Preliminary evaluation indicates that a self-administered form provides accurate and more complete information regarding chemotherapy toxicity than a simple patient interview. It is not limited by the setting.


CONCLUSIONS
The self-report form allows the nurse to assess chemotherapy toxicity and to make dose modifications as necessary, regardless of the patient's clinical trial status.
Brinkman
P
P
Midwest Cooperative Group Outreach Program (MCGOP), Saint Luke's Hospital, Kansas City, MO.
Hay
D
D
Laubinger
P
P
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D005568:Forms and Records Control; D006801:Humans; D008499:Medical Records